Australia-based Mayne Pharma sells US generic prescription product portfolio for $90 M
Generics | News | 0 Comment | 28 Feb, 2023
Dr. Reddy's Laboratories SA, a wholly-owned subsidiary of Indian pharmaceutical company Dr. Reddy’s Laboratories, ...Read more
Indian pharma firm Venus Remedies gets marketing approval for cancer drugs in Uzbekistan, Palestine
Generics | News | 0 Comment | 23 Feb, 2023
Indian pharmaceutical company Venus Remedies has received marketing authorisation for its generic cancer drugs from Uzbe...Read more
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
Generics | News | 0 Comment | 28 Sep, 2022
Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...Read more
Generics | News | 0 Comment | 08 Aug, 2022
Pharmaceutical companies need to ensure they have a competitive edge in the market while adapting to evolving industry b...Read more
35 manufacturers sign agreements to produce generic versions of Pfizer's oral COVID-19 drug
Generics | News | 0 Comment | 18 Mar, 2022
The Medicines Patent Pool (MPP) has signed agreements with 35 companies to manufacture the generic version of Pfizer's o...Read more
Taiwan approves new first-line treatment for advanced renal cell carcinoma
Generics | News | 0 Comment | 31 Jan, 2022
Eisai Co. has announced that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inh...Read more
Eisai to market Gilead’s rheumatoid arthritis drug in Asia
Generics | News | 0 Comment | 23 Dec, 2021
Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...Read more
Biocon partners with Tabuk Pharma to commercialise speciality generic medicines in Middle East
Generics | News | 0 Comment | 08 Dec, 2021
Indian firm Biocon has announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary...Read more
C2 PHARMA Completes Multiple Local Regulatory Filings and Expands Portfolio
Generics | News | 0 Comment | 10 Nov, 2021
Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Kor...Read more
Patient access to gene therapies for cancer set to increase in next decade: GlobalData
Generics | News | 0 Comment | 25 Jun, 2021
Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies acros...Read more
Bayer leads Metagenomi complete $65M series A financing round
Generics | News | 0 Comment | 16 Nov, 2020
US-based Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully com...Read more
Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes
Generics | News | 0 Comment | 21 May, 2020
These EVs are known to mediate many of the therapeutic effects of stem cells. The authors show that Austrianova’s ...Read more
Indian Pharma market to raise from US$34.3bn in 2020 to more than US$45bn by 2025
Generics | News | 0 Comment | 24 Feb, 2020
Following the recent news that Dr Reddy's Laboratories (DRL) has agreed to acquire Wockhardt Ltd’s select division...Read more
Towa to acquire Esteve’s generic division for 320M euros
Generics | News | 0 Comment | 24 Dec, 2019
Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...Read more
Panacea Biotec launches diabetes drug in India
Generics | News | 0 Comment | 11 Dec, 2019
Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled T...Read more
HEC Pharm, Biocon, Sun Pharma get FDA approval for MS drug
Generics | News | 2 Comment | 06 Dec, 2019
The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsule...Read more
Eris Lifesciences acquires trademark Zomelis from Novartis for India market
Generics | News | 0 Comment | 04 Dec, 2019
Eris Lifesciences has announced the acquisition of the trademark Zomelis (for Vildagliptin based formulations)...Read more
EMA and FDA accept marketing applications for Chugai's Satralizumab
Generics | News | 0 Comment | 31 Oct, 2019
Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...Read more